Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study

Exclusion Criteria

• •Concurrent treatment with antipsychotic agents =\< 12 hours prior to randomization
• •for depot agents a period of two weeks or one cycle, whichever is the longer, must occur between last administration and randomization
• •Treatment with antidepressants or mood stabilizers =\< 7 days of randomization
• •for MAOIs and moclobemide this period must =\< 2 weeks
• •for fluoxetine =\< 5 weeks